← Eichor
Study identifier: NCT07465302 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treating Spinal Cord Injury With Early Normobaric Hyperoxia

Condition: Traumatic Spinal Cord Injuries  ·  Sponsor: University of Florida

PhasePhase 2
Planned participants12
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.

This description comes directly from the study's public registry record.

Talk to the study team

Andrew Kline  ·  352-273-9000  ·  andrew.kline@neurosurgery.ufl.edu

Ralisa Pop  ·  (352) 294-5693  ·  Ralisa.Pop@neurology.ufl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of FloridaGainesville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07465302